Colorectal Quiz Episode 26: Perianal Crohn's Disease
In pediatric patients, unlike adult patients, the first presenting factor for Crohn's disease can often be perianal disease.
Male gender over the age of 10, and presence of a fistula are risk factors with much higher incidence of Crohn's disease being diagnosed in patients presenting with perianal lesions to the emergency room.
The mucosa heals first compared to skin in perianal disease, so leaving a mucosal opening without a seton risks recurrent abscess when biologics heal the mucosa.
Making a large cruciate incision and packing a perianal abscess in a child with undiagnosed Crohn's disease may result in non-healing and potentially require colostomy or ileostomy.
The highest risk factors for lymphoma with biologic therapy are male gender, teenage age, and combination therapy with methotrexate.
Real risks of biologic agents include infectious complications such as tuberculosis and risk of lymphoma.
When the colonoscope cannot intubate the terminal ileum, capsule endoscopy or fecal calprotectin can be used to aid diagnosis.
If terminal ileum cannot be intubated, gastroenterologists may treat presumptively and re-scope after a few months of treatment when inflammation has decreased.
Setons should remain in place for at least 6 months to allow the inflammatory tract to become non-inflammatory.
Before removing a seton, the bottom must look better, drainage must be better, the patient must be symptom-free, and they must have reached steady state of biologic (loading dose plus at least 3 more doses, typically 2-3 months from start).
Inflammatory markers including fecal calprotectin, ESR, and CRP should be checked before removing a seton to ensure systemic disease is under control.
The initial Remicade paper from 1998 or 1999 in the New England Journal of Medicine was on perianal disease and demonstrated improved healing time and improved length of time between recurrence when combination of seton and infliximab is used versus either separately.
Remicade (infliximab) has the most literature on healing perianal disease; Humira also has good evidence but less literature; Stelara and vedolizumab are sometimes used with less information available.
Literature shows about a 10% response rate for perianal fistulas even without biologics if a seton is placed and removed, with much better outcomes with biologics.
Source control of infection must be achieved before starting immunosuppressive therapy including steroids and biologics.
If an abscess is not adequately drained, reimaging should be performed before giving biologics or steroids.
Hydrogen peroxide is preferred over methylene blue for identifying fistula tracts because it is neater; 3% hydrogen peroxide in a syringe with 16-20 gauge angiocath is used with a speculum in the anus.
When a fistula opening cannot be found despite hydrogen peroxide testing, a seton should not be placed at that time to avoid creating a hole where there isn't one.
For recurrent patients requiring repeat seton placement, repeat imaging should be obtained before seton removal.
It is common to have perianal disease in Crohn's; this patient had a delay in diagnosis and had perianal disease for quite some time with multiple skin tags and fissures.
Inflammatory Bowel Disease (IBD) - Samir Pandya: Update Course 2014
In a review study published recently, CT enterography is more accurate than MR enterography for Crohn's disease, though institutional radiologist expertise determines which modality performs better in practice.
Host summarySamir Pandya summarizing a resource — not the host's own clinical position0:00
Children presenting with Crohn's disease for the first time with a perianal or perirectal abscess often have non-colonic small intestinal disease.
Contrast-enhanced ultrasound has sensitivity and specificity as high as 100% for Crohn's disease in previously undiagnosed patients, and above 95% in patients with known diagnosis, according to the Peloda study published in Pediatrics 2013.
Host summarySamir Pandya summarizing a resource — not the host's own clinical position4:00
Contrast-enhanced ultrasound is only available for clinical use in Europe at present and has not been approved by the FDA.
Host summarySamir Pandya summarizing a resource — not the host's own clinical position4:00
In Europe, ultrasound is the first-line imaging choice for Crohn's disease, followed by MR or CT enterography, whereas in the US, MR/CT enterography is first-line.
Host summarySamir Pandya summarizing a resource — not the host's own clinical position5:00
MR enterography provides information about the chronicity of Crohn's disease strictures, helping determine whether a stricture is chronic and fibrotic (unlikely to resolve with medication) or potentially responsive to medical therapy.
Host summarySamir Pandya summarizing a resource — not the host's own clinical position6:00
Perianal abscesses in Crohn's disease are unlikely to heal without fecal diversion because bowel continuity slows healing.
Expert opinionSamir Pandya10:00
Modern TNF inhibitor drugs are effective at healing perianal disease in Crohn's, potentially allowing avoidance of fecal diversion in selected patients.
Patients and parents would rather deal with a chronic perianal problem than manage a stoma.
Expert opinionSamir Pandya12:00
Most Crohn's perianal abscesses are not single; when draining a perianal abscess in Crohn's disease, there are usually several fistulas present.